Report cover image

Global Medicated Adhesive Patch Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 117 Pages
SKU # APRC20549601

Description

Summary

According to APO Research, The global Medicated Adhesive Patch market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Medicated Adhesive Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Medicated Adhesive Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Medicated Adhesive Patch is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Medicated Adhesive Patch include Johnson & Johnson, Novartis, Mylan, Pfizer, GSK, Beijing Tide Pharmaceutical, Bayer, UCB Pharma and Teva Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medicated Adhesive Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicated Adhesive Patch.
The Medicated Adhesive Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medicated Adhesive Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Medicated Adhesive Patch Segment by Company

Johnson & Johnson
Novartis
Mylan
Pfizer
GSK
Beijing Tide Pharmaceutical
Bayer
UCB Pharma
Teva Pharmaceutical
Nitto Denko
Mundipharma
Luye Pharma Group
IBSA Group
Hisamitsu Pharmaceutical
Grünenthal
Endo International
Dr Reddy’s Laboratories
Chattem
Medicated Adhesive Patch Segment by Type

Methyl Salicylate-based Patch
Nicotine Transdermal Patch
Rivastigmine Transdermal Patch
Clonidine Transdermal Patch
Fentanyl Transdermal Patch
Oxybutynin Transdermal Patch
Others
Medicated Adhesive Patch Segment by Application

Used to Treat High Blood Pressure
Used to Treat an Overactive Bladder
Used to Relieve Severe Pain
Used to Stop Smoking Cigarettes
Others
Medicated Adhesive Patch Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medicated Adhesive Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medicated Adhesive Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medicated Adhesive Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medicated Adhesive Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Medicated Adhesive Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

117 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Medicated Adhesive Patch Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Medicated Adhesive Patch Sales Estimates and Forecasts (2020-2031)
1.3 Medicated Adhesive Patch Market by Type
1.3.1 Methyl Salicylate-based Patch
1.3.2 Nicotine Transdermal Patch
1.3.3 Rivastigmine Transdermal Patch
1.3.4 Clonidine Transdermal Patch
1.3.5 Fentanyl Transdermal Patch
1.3.6 Oxybutynin Transdermal Patch
1.3.7 Others
1.4 Global Medicated Adhesive Patch Market Size by Type
1.4.1 Global Medicated Adhesive Patch Market Size Overview by Type (2020-2031)
1.4.2 Global Medicated Adhesive Patch Historic Market Size Review by Type (2020-2025)
1.4.3 Global Medicated Adhesive Patch Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Medicated Adhesive Patch Sales Breakdown by Type (2020-2025)
1.5.2 Europe Medicated Adhesive Patch Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Medicated Adhesive Patch Sales Breakdown by Type (2020-2025)
1.5.4 South America Medicated Adhesive Patch Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Medicated Adhesive Patch Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Medicated Adhesive Patch Industry Trends
2.2 Medicated Adhesive Patch Industry Drivers
2.3 Medicated Adhesive Patch Industry Opportunities and Challenges
2.4 Medicated Adhesive Patch Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Medicated Adhesive Patch Revenue (2020-2025)
3.2 Global Top Players by Medicated Adhesive Patch Sales (2020-2025)
3.3 Global Top Players by Medicated Adhesive Patch Price (2020-2025)
3.4 Global Medicated Adhesive Patch Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Medicated Adhesive Patch Major Company Production Sites & Headquarters
3.6 Global Medicated Adhesive Patch Company, Product Type & Application
3.7 Global Medicated Adhesive Patch Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Medicated Adhesive Patch Market CR5 and HHI
3.8.2 Global Top 5 and 10 Medicated Adhesive Patch Players Market Share by Revenue in 2024
3.8.3 2023 Medicated Adhesive Patch Tier 1, Tier 2, and Tier 3
4 Medicated Adhesive Patch Regional Status and Outlook
4.1 Global Medicated Adhesive Patch Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Medicated Adhesive Patch Historic Market Size by Region
4.2.1 Global Medicated Adhesive Patch Sales in Volume by Region (2020-2025)
4.2.2 Global Medicated Adhesive Patch Sales in Value by Region (2020-2025)
4.2.3 Global Medicated Adhesive Patch Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Medicated Adhesive Patch Forecasted Market Size by Region
4.3.1 Global Medicated Adhesive Patch Sales in Volume by Region (2026-2031)
4.3.2 Global Medicated Adhesive Patch Sales in Value by Region (2026-2031)
4.3.3 Global Medicated Adhesive Patch Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Medicated Adhesive Patch by Application
5.1 Medicated Adhesive Patch Market by Application
5.1.1 Used to Treat High Blood Pressure
5.1.2 Used to Treat an Overactive Bladder
5.1.3 Used to Relieve Severe Pain
5.1.4 Used to Stop Smoking Cigarettes
5.1.5 Others
5.2 Global Medicated Adhesive Patch Market Size by Application
5.2.1 Global Medicated Adhesive Patch Market Size Overview by Application (2020-2031)
5.2.2 Global Medicated Adhesive Patch Historic Market Size Review by Application (2020-2025)
5.2.3 Global Medicated Adhesive Patch Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Medicated Adhesive Patch Sales Breakdown by Application (2020-2025)
5.3.2 Europe Medicated Adhesive Patch Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Medicated Adhesive Patch Sales Breakdown by Application (2020-2025)
5.3.4 South America Medicated Adhesive Patch Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Medicated Adhesive Patch Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Comapny Information
6.1.2 Johnson & Johnson Business Overview
6.1.3 Johnson & Johnson Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Medicated Adhesive Patch Product Portfolio
6.1.5 Johnson & Johnson Recent Developments
6.2 Novartis
6.2.1 Novartis Comapny Information
6.2.2 Novartis Business Overview
6.2.3 Novartis Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis Medicated Adhesive Patch Product Portfolio
6.2.5 Novartis Recent Developments
6.3 Mylan
6.3.1 Mylan Comapny Information
6.3.2 Mylan Business Overview
6.3.3 Mylan Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mylan Medicated Adhesive Patch Product Portfolio
6.3.5 Mylan Recent Developments
6.4 Pfizer
6.4.1 Pfizer Comapny Information
6.4.2 Pfizer Business Overview
6.4.3 Pfizer Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Medicated Adhesive Patch Product Portfolio
6.4.5 Pfizer Recent Developments
6.5 GSK
6.5.1 GSK Comapny Information
6.5.2 GSK Business Overview
6.5.3 GSK Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GSK Medicated Adhesive Patch Product Portfolio
6.5.5 GSK Recent Developments
6.6 Beijing Tide Pharmaceutical
6.6.1 Beijing Tide Pharmaceutical Comapny Information
6.6.2 Beijing Tide Pharmaceutical Business Overview
6.6.3 Beijing Tide Pharmaceutical Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Beijing Tide Pharmaceutical Medicated Adhesive Patch Product Portfolio
6.6.5 Beijing Tide Pharmaceutical Recent Developments
6.7 Bayer
6.7.1 Bayer Comapny Information
6.7.2 Bayer Business Overview
6.7.3 Bayer Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bayer Medicated Adhesive Patch Product Portfolio
6.7.5 Bayer Recent Developments
6.8 UCB Pharma
6.8.1 UCB Pharma Comapny Information
6.8.2 UCB Pharma Business Overview
6.8.3 UCB Pharma Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.8.4 UCB Pharma Medicated Adhesive Patch Product Portfolio
6.8.5 UCB Pharma Recent Developments
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Comapny Information
6.9.2 Teva Pharmaceutical Business Overview
6.9.3 Teva Pharmaceutical Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Teva Pharmaceutical Medicated Adhesive Patch Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments
6.10 Nitto Denko
6.10.1 Nitto Denko Comapny Information
6.10.2 Nitto Denko Business Overview
6.10.3 Nitto Denko Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nitto Denko Medicated Adhesive Patch Product Portfolio
6.10.5 Nitto Denko Recent Developments
6.11 Mundipharma
6.11.1 Mundipharma Comapny Information
6.11.2 Mundipharma Business Overview
6.11.3 Mundipharma Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Mundipharma Medicated Adhesive Patch Product Portfolio
6.11.5 Mundipharma Recent Developments
6.12 Luye Pharma Group
6.12.1 Luye Pharma Group Comapny Information
6.12.2 Luye Pharma Group Business Overview
6.12.3 Luye Pharma Group Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Luye Pharma Group Medicated Adhesive Patch Product Portfolio
6.12.5 Luye Pharma Group Recent Developments
6.13 IBSA Group
6.13.1 IBSA Group Comapny Information
6.13.2 IBSA Group Business Overview
6.13.3 IBSA Group Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.13.4 IBSA Group Medicated Adhesive Patch Product Portfolio
6.13.5 IBSA Group Recent Developments
6.14 Hisamitsu Pharmaceutical
6.14.1 Hisamitsu Pharmaceutical Comapny Information
6.14.2 Hisamitsu Pharmaceutical Business Overview
6.14.3 Hisamitsu Pharmaceutical Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hisamitsu Pharmaceutical Medicated Adhesive Patch Product Portfolio
6.14.5 Hisamitsu Pharmaceutical Recent Developments
6.15 Grünenthal
6.15.1 Grünenthal Comapny Information
6.15.2 Grünenthal Business Overview
6.15.3 Grünenthal Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Grünenthal Medicated Adhesive Patch Product Portfolio
6.15.5 Grünenthal Recent Developments
6.16 Endo International
6.16.1 Endo International Comapny Information
6.16.2 Endo International Business Overview
6.16.3 Endo International Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Endo International Medicated Adhesive Patch Product Portfolio
6.16.5 Endo International Recent Developments
6.17 Dr Reddy’s Laboratories
6.17.1 Dr Reddy’s Laboratories Comapny Information
6.17.2 Dr Reddy’s Laboratories Business Overview
6.17.3 Dr Reddy’s Laboratories Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Dr Reddy’s Laboratories Medicated Adhesive Patch Product Portfolio
6.17.5 Dr Reddy’s Laboratories Recent Developments
6.18 Chattem
6.18.1 Chattem Comapny Information
6.18.2 Chattem Business Overview
6.18.3 Chattem Medicated Adhesive Patch Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Chattem Medicated Adhesive Patch Product Portfolio
6.18.5 Chattem Recent Developments
7 North America by Country
7.1 North America Medicated Adhesive Patch Sales by Country
7.1.1 North America Medicated Adhesive Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Medicated Adhesive Patch Sales by Country (2020-2025)
7.1.3 North America Medicated Adhesive Patch Sales Forecast by Country (2026-2031)
7.2 North America Medicated Adhesive Patch Market Size by Country
7.2.1 North America Medicated Adhesive Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Medicated Adhesive Patch Market Size by Country (2020-2025)
7.2.3 North America Medicated Adhesive Patch Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Medicated Adhesive Patch Sales by Country
8.1.1 Europe Medicated Adhesive Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Medicated Adhesive Patch Sales by Country (2020-2025)
8.1.3 Europe Medicated Adhesive Patch Sales Forecast by Country (2026-2031)
8.2 Europe Medicated Adhesive Patch Market Size by Country
8.2.1 Europe Medicated Adhesive Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Medicated Adhesive Patch Market Size by Country (2020-2025)
8.2.3 Europe Medicated Adhesive Patch Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Medicated Adhesive Patch Sales by Country
9.1.1 Asia-Pacific Medicated Adhesive Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Medicated Adhesive Patch Sales by Country (2020-2025)
9.1.3 Asia-Pacific Medicated Adhesive Patch Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Medicated Adhesive Patch Market Size by Country
9.2.1 Asia-Pacific Medicated Adhesive Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Medicated Adhesive Patch Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Medicated Adhesive Patch Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Medicated Adhesive Patch Sales by Country
10.1.1 South America Medicated Adhesive Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Medicated Adhesive Patch Sales by Country (2020-2025)
10.1.3 South America Medicated Adhesive Patch Sales Forecast by Country (2026-2031)
10.2 South America Medicated Adhesive Patch Market Size by Country
10.2.1 South America Medicated Adhesive Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Medicated Adhesive Patch Market Size by Country (2020-2025)
10.2.3 South America Medicated Adhesive Patch Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Medicated Adhesive Patch Sales by Country
11.1.1 Middle East and Africa Medicated Adhesive Patch Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Medicated Adhesive Patch Sales by Country (2020-2025)
11.1.3 Middle East and Africa Medicated Adhesive Patch Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Medicated Adhesive Patch Market Size by Country
11.2.1 Middle East and Africa Medicated Adhesive Patch Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Medicated Adhesive Patch Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Medicated Adhesive Patch Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Medicated Adhesive Patch Value Chain Analysis
12.1.1 Medicated Adhesive Patch Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Medicated Adhesive Patch Production Mode & Process
12.2 Medicated Adhesive Patch Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Medicated Adhesive Patch Distributors
12.2.3 Medicated Adhesive Patch Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.